Rocket Pharmaceuticals, Inc.
RCKT$1.40B
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEW YORK299 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
May 5, 2026
7wMarket Overview
Stock performance and key metrics
RCKT News
Catalyst Timeline
2 upcoming, 0 past
Fanconi Anemia Complementation Group A
1 drug in this indication
Leukocyte Adhesion Defect - Type I
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply